| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 检验试剂(IVD)(元) | 1,411,463,062.62 | 2,339,019,243.46 | 976,472,476.63 |
| 外科器械(元) | 1,858,810,770.87 | 3,846,778,416.49 | 1,824,808,700.62 |
| 血管介入(元) | 5,394,381,622.32 | 9,966,587,739.52 | 5,079,747,602.63 |
| 医疗设备(元) | 567,606,181.13 | 1,117,850,647.54 | 559,629,281.95 |
| SPD及其他服务(元) | 119,521,533.12 | 112,388,919.41 | 43,390,979.12 |
| 其他医疗器械(元) | 461,384,291.67 | 499,721,050.86 | 255,881,227.47 |
| 营业成本(元) | |||
| 检验试剂(IVD)(元) | 1,177,714,449.89 | 1,949,750,766.10 | 795,438,255.93 |
| 外科器械(元) | 1,709,938,786.64 | 3,545,156,957.80 | 1,672,612,546.40 |
| 血管介入(元) | 5,125,666,464.90 | 9,465,138,486.85 | 4,824,087,542.44 |
| 医疗设备(元) | 532,875,438.18 | 1,047,105,209.61 | 525,640,472.68 |
| SPD及其他服务(元) | 47,441,358.05 | 67,659,025.60 | 29,503,876.54 |
| 其他医疗器械(元) | 442,295,252.47 | 472,983,030.54 | 238,954,045.81 |
| 毛利(元) | |||
| 检验试剂(IVD)(元) | 233,748,612.73 | 389,268,477.36 | 181,034,220.70 |
| 外科器械(元) | 148,871,984.23 | 301,621,458.69 | 152,196,154.22 |
| 血管介入(元) | 268,715,157.42 | 501,449,252.67 | 255,660,060.19 |
| 医疗设备(元) | 34,730,742.95 | 70,745,437.93 | 33,988,809.27 |
| SPD及其他服务(元) | 72,080,175.07 | 44,729,893.81 | 13,887,102.58 |
| 其他医疗器械(元) | 19,089,039.20 | 26,738,020.32 | 16,927,181.66 |
| 毛利率(%) | |||
| 检验试剂(IVD)(%) | 16.56 | 16.64 | 18.54 |
| 外科器械(%) | 8.01 | 7.84 | 8.34 |
| 血管介入(%) | 4.98 | 5.03 | 5.03 |
| 医疗设备(%) | 6.12 | 6.33 | 6.07 |
| SPD及其他服务(%) | 60.31 | 39.80 | 32.00 |
| 其他医疗器械(%) | 4.14 | 5.35 | 6.62 |
| 收入构成(%) | |||
| 检验试剂(IVD)(%) | 14.38 | 13.08 | 11.17 |
| 外科器械(%) | 18.94 | 21.51 | 20.88 |
| 血管介入(%) | 54.97 | 55.73 | 58.12 |
| 医疗设备(%) | 5.78 | 6.25 | 6.40 |
| SPD及其他服务(%) | 1.22 | 0.63 | 0.50 |
| 其他医疗器械(%) | 4.70 | 2.79 | 2.93 |
| 毛利构成(%) | |||
| 检验试剂(IVD)(%) | 30.07 | 29.17 | 27.69 |
| 外科器械(%) | 19.15 | 22.60 | 23.28 |
| 血管介入(%) | 34.57 | 37.57 | 39.11 |
| 医疗设备(%) | 4.47 | 5.30 | 5.20 |
| SPD及其他服务(%) | 9.27 | 3.35 | 2.12 |
| 其他医疗器械(%) | 2.46 | 2.00 | 2.59 |